17-82080880-T-C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_004104.5(FASN):​c.6638A>G​(p.Gln2213Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000407 in 1,611,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 0 hom. )

Consequence

FASN
NM_004104.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: -0.180

Publications

2 publications found
Variant links:
Genes affected
FASN (HGNC:3594): (fatty acid synthase) The enzyme encoded by this gene is a multifunctional protein. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-alpha. [provided by RefSeq, Jul 2008]
FASN Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.037053943).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FASNNM_004104.5 linkc.6638A>G p.Gln2213Arg missense_variant Exon 39 of 43 ENST00000306749.4 NP_004095.4 P49327
FASNXM_011523538.3 linkc.6638A>G p.Gln2213Arg missense_variant Exon 39 of 43 XP_011521840.1 P49327

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FASNENST00000306749.4 linkc.6638A>G p.Gln2213Arg missense_variant Exon 39 of 43 1 NM_004104.5 ENSP00000304592.2 P49327
FASNENST00000634990.1 linkc.6632A>G p.Gln2211Arg missense_variant Exon 39 of 43 5 ENSP00000488964.1 A0A0U1RQF0
FASNENST00000578424.2 linkn.-185A>G upstream_gene_variant 2
FASNENST00000580382.1 linkn.-140A>G upstream_gene_variant 3 ENSP00000462949.1 J3KTF0

Frequencies

GnomAD3 genomes
AF:
0.000243
AC:
37
AN:
152218
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000156
AC:
38
AN:
242974
AF XY:
0.000151
show subpopulations
Gnomad AFR exome
AF:
0.000193
Gnomad AMR exome
AF:
0.000147
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000275
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000424
AC:
618
AN:
1458914
Hom.:
0
Cov.:
33
AF XY:
0.000442
AC XY:
321
AN XY:
725580
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33464
American (AMR)
AF:
0.000112
AC:
5
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26084
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39660
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85842
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51994
Middle Eastern (MID)
AF:
0.000536
AC:
3
AN:
5596
European-Non Finnish (NFE)
AF:
0.000510
AC:
567
AN:
1111490
Other (OTH)
AF:
0.000647
AC:
39
AN:
60284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000243
AC:
37
AN:
152218
Hom.:
0
Cov.:
33
AF XY:
0.000242
AC XY:
18
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41456
American (AMR)
AF:
0.000262
AC:
4
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000412
AC:
28
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000608
Hom.:
0
Bravo
AF:
0.000253
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000466
AC:
4
ExAC
AF:
0.000141
AC:
17
EpiCase
AF:
0.000436
EpiControl
AF:
0.000179

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epileptic encephalopathy Uncertain:2
Jul 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 2213 of the FASN protein (p.Gln2213Arg). This variant is present in population databases (rs142275662, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FASN-related conditions. ClinVar contains an entry for this variant (Variation ID: 578508). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Nov 15, 2019
Knight Diagnostic Laboratories, Oregon Health and Sciences University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
May 28, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.6638A>G (p.Q2213R) alteration is located in exon 39 (coding exon 38) of the FASN gene. This alteration results from a A to G substitution at nucleotide position 6638, causing the glutamine (Q) at amino acid position 2213 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
2.2
DANN
Benign
0.16
DEOGEN2
Benign
0.27
T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.56
T;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.037
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.5
L;.
PhyloP100
-0.18
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.83
N;.
REVEL
Benign
0.0080
Sift
Benign
0.42
T;.
Sift4G
Benign
0.53
T;T
Polyphen
0.0020
B;.
Vest4
0.23
MVP
0.48
ClinPred
0.010
T
GERP RS
-4.9
Varity_R
0.036
gMVP
0.43
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142275662; hg19: chr17-80038756; API